The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease

IŞIK A. T., Soysal P., Yay A., Usarel C.

DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.123, ss.192-198, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 123
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.diabres.2016.12.010
  • Dergi Adı: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.192-198
  • Anahtar Kelimeler: Sitagliptin, Cognitive function, Alzheimer disease, Dementia, Elderly, BRAIN INSULIN-RESISTANCE, GROWTH-FACTOR EXPRESSION, OXIDATIVE STRESS, IMPAIRMENT, RELEVANCE, THERAPY, RISK, RATS
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Aims: The present study aimed to evaluate effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4I), on cognitive functions in elderly diabetic patients with and without cognitive impairment.